日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis

体内抗FAP CAR-T疗法可减少代谢功能障碍相关性脂肪性肝炎中的纤维化并恢复肝脏稳态

Yashaswini, Chittampalli N; Cogliati, Bruno; Qin, Tianyue; To, Tran; Williamson, Thomas; Papp, Tyler E; Li, Kenneth; Rasul, Raisa; Chen, Li; Lightstone, Adi; Aghajanian, Haig; Parhiz, Hamideh; Wang, Shuang; Rurik, Joel G; Epstein, Jonathan A; Friedman, Scott L

Immunomodulatory Therapy for Ischemic Heart Disease

缺血性心脏病的免疫调节疗法

Zhao, Xinye; Williamson, Thomas; Gong, Yanqing; Epstein, Jonathan A; Fan, Yi

Emerging mRNA therapies for cardiac fibrosis

新兴的mRNA疗法治疗心脏纤维化

Jardin, Blake; Epstein, Jonathan A

Linking immune modulation to cardiac fibrosis

将免疫调节与心脏纤维化联系起来

Bengel, Frank; Epstein, Jonathan A; Gropler, Robert; Haberkorn, Uwe; Kramann, Rafael; Lavine, Kory; Leuschner, Florian; Liu, Yongjian; Rosenthal, Nadia; Wu, Hao

CAR T therapy beyond cancer: the evolution of a living drug

CAR-T疗法超越癌症:活体药物的演变

Baker, Daniel J; Arany, Zoltan; Baur, Joseph A; Epstein, Jonathan A; June, Carl H

CAR-based therapies: opportunities for immuno-medicine beyond cancer

基于CAR的疗法:癌症以外的免疫医学机遇

Aghajanian, Haig; Rurik, Joel G; Epstein, Jonathan A

Uniting Disciplines to Develop Therapeutics: Targeted mRNA Lipid Nanoparticles Reprogram the Immune System In Vivo to Treat Heart Disease

跨学科融合研发疗法:靶向mRNA脂质纳米颗粒在体内重编程免疫系统以治疗心脏病

Rurik, Joel G; Epstein, Jonathan A

Immune Cells and Immunotherapy for Cardiac Injury and Repair

免疫细胞和免疫疗法在心脏损伤和修复中的应用

Rurik, Joel G; Aghajanian, Haig; Epstein, Jonathan A

CARTing Away Cardiac Fibrosis

消除心脏纤维化

Epstein, Jonathan A

An Engineered Mouse to Identify Proliferating Cells and Their Derivatives

利用基因工程小鼠识别增殖细胞及其衍生物

Jang, Jihyun; Engleka, Kurt A; Liu, Feiyan; Li, Li; Song, Guang; Epstein, Jonathan A; Li, Deqiang